FDA Broadens Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Issues
Esperion (NASDAQ: ESPR) announced today that the FDA has approved expanded labels for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets. This approval is based on positive CLEAR Outcomes data and includes indications for cardiovascular risk reduction…
Meridian Health Plan Offers Incentives for Hospital Equity Certification
Meridian Health Plan of Illinois, Inc. (Meridian), a company that provides managed care services under government sponsorship to various segments of the population such as families, children, seniors, and individuals with complex medical needs, announced today that it will offer…
Superior HealthPlan’s Annual Community Investment Report Released
Superior HealthPlan, a key managed care organization in Texas and a subsidiary of Centene Corporation, has released its annual community investment report. The report underscores Superior’s dedication to enhancing the well-being of individuals and families across the state. In 2023,…
UnitedHealth Group Cyberattack Status Update
UnitedHealth Group (NYSE: UNH) is making strides in addressing the impact of the recent cyberattack on the U.S. health system and Change Healthcare services. The company is expanding financial support for affected providers while taking steps to restore services. Change…
Spectrum Solutions® Unveil Simply PERIO™ Saliva Test with Simply Test® Power
Spectrum Solutions®, a leading saliva diagnostic biotech company, has launched SimplyPERIO™, a new saliva diagnostic testing solution. This innovative test addresses the growing focus on the mouth-body connection and its impact on overall health. SimplyPERIO™ offers comprehensive health insights by…
Minneapolis Clinic Adds Vagus Nerve Stimulation for Severe Depression
The Advanced Brain + Body Clinic Ketamine TMS (AB+BC), experts in addressing treatment-resistant depression and severe mental health disorders, has included Vagus Nerve Stimulation (VNS) in its treatment options. VNS, approved by the FDA, is a non-medication therapy suitable for…
Vista.ai Names Daniel Hawkins as CEO
VISTA.AI has named Daniel Hawkins as its new President and CEO. The company specializes in AI-driven MRI image acquisition, aiming to enable MRI technicians to generate high-quality scans efficiently and affordably for various complex indications. Daniel’s appointment comes at a…
ImpriMed Showcasing Innovative Research at 2024 World Vet Cancer Congress
ImpriMed, a top precision medicine startup using AI for cancer treatment advancement, shared its participation in the World Veterinary Cancer Congress (WVCC) 2024 in Tokyo, Japan, from March 21-24, 2024. CEO Dr. Sungwon Lim and CTO Dr. Jamin Koo will…
PocketHealth Secures $33M in Series B Funding
PocketHealth, the leader in patient-centric medical image exchange, today announced it has raised $33 million USD ($45 million CAD) in Series B funding. The all-equity round was led by Round13 Capital with participation from Deloitte Ventures, Samsung Next, and existing…
Butterfly iQ+ Devices Obtain EU MDR Certification
Butterfly Network, Inc. (NYSE: BFLY), a digital health company known for its portable ultrasound system based on semiconductors and intuitive software, has announced that it has achieved its Certificate of Compliance with the European Medical Device Regulation (EU MDR) for…
Samsung Receives Healthcare Innovator Award for Underserved Communities Care
Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound division, received HHM Health’s Healthcare Innovator Award for its SonoSync technology and efforts to improve healthcare access for underserved communities. The award was accepted during HHM Health’s Healing Hands…
IIPA Boosts Antibody Discovery with Carterra LSA® Instrument Acquisition
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (NASDAQ: IPA), a biotherapeutics research and technology company driven by artificial intelligence, has acquired Carterra’s LSA® instrument platform. This high-throughput screening and characterization solution enhances IPA’s capabilities in antibody characterization through surface plasmon resonance, enabling advanced…